Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.24.3
Balance Sheet Components
 9 Months Ended
Sep. 30, 2024
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2023 and September 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2023     2024  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 270     $ 397  
Prepaid preclinical services     3,103       4,310  
Other     325       687  
Total   $ 3,698     $ 5,394  

 

Property, plant and equipment as of December 31, 2023 and September 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2023     2024  
             
Leasehold improvements   $ 21     $ 37  
Furniture and fixtures     21       29  
Lab Equipment    
-
       26  
Subtotal     42       92  
Less accumulated depreciation     (16 )     (31 )
Net   $ 26     $ 61  

 

Accounts payable as of December 31, 2023 and September 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2023     2024  
             
Trade accounts payable   $ 821     $ 519  
Credit card liability     18       29  
Total   $ 839     $ 548  

 

Accrued liabilities as of December 31, 2023 and September 30, 2024 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2023     2024  
             
Accrued labor costs   $ 1,917     $ 1,402  
Accrued drug development costs     1,034       1,068  
Other     283       522  
Total   $ 3,234     $ 2,992